NFL Biosciences SA(FR:ALNFL)
€0.40+0.01 (+1.53%)
FR:ALNFL
NFL Biosciences SA financials statements
€0.40
At close:+0.01 (+1.53%)
NFL Biosciences SA (ALNFL) Financial Statements
1 Followers
NFL Biosciences SA Financial Overview
NFL Biosciences SA's market cap is currently €4.93M. The company's EPS TTM is €-0.24; its P/E ratio is -1.65; NFL Biosciences SA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 0.00 | € 46.00 | € 200.01K | € 0.00 | € 39.00 |
| Gross Profit | € -2.52M | € -67.14K | € -56.06K | € -2.24M | € -530.73K |
| Operating Income | € -3.87M | € -2.79M | € -4.43M | € -3.01M | € -901.87K |
| EBITDA | € -3.76M | € -2.65M | € -4.05M | € -2.81M | € -1.08M |
| Net Income | € -3.32M | € -2.08M | € -3.75M | € -2.44M | € -978.24K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 2.20M | € 2.11M | € 2.53M | € 1.21M | € 3.20M |
| Total Assets | € 3.66M | € 3.61M | € 3.97M | € 2.40M | € 3.69M |
| Total Debt | € 582.59K | € 40.98K | € 62.17K | € 83.26K | € 85.01K |
| Net Debt | € -1.42M | € -1.87M | € -2.28M | € -970.33K | € -2.95M |
| Total Liabilities | € 3.36M | € 2.63M | € 3.62M | € 1.55M | € 397.73K |
| Stockholders' Equity | € 306.14K | € 976.43K | € 349.94K | € 844.00K | € 3.29M |
| Cash Flow | |||||
| Free Cash Flow | € 0.00 | € 0.00 | € 0.00 | € 104.89K | € 87.00K |
| Operating Cash Flow | € 0.00 | € 0.00 | € 0.00 | € 104.89K | € 87.00K |
| Investing Cash Flow | € 0.00 | € 0.00 | € 0.00 | € 0.00 | € 0.00 |
| Financing Cash Flow | € 0.00 | € 0.00 | € 0.00 | € 0.00 | € 0.00 |
Currency in EUR
